Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,439 | -12,491 | -9,759 | -5,799 | -2,115 |
| Depreciation Amortization | 31 | 115 | 84 | 54 | 26 |
| Other Working Capital | -689 | 329 | 884 | 491 | 176 |
| Other Operating Activity | 561 | 2,283 | 1,654 | 1,159 | 125 |
| Operating Cash Flow | $-2,536 | $-9,764 | $-7,137 | $-4,095 | $-1,788 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -15 | -15 | -15 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -247 | N/A | N/A |
| Other Investing Activity | -215 | -320 | -247 | -108 | -48 |
| Investing Cash Flow | $-231 | $-335 | $-262 | $-123 | $-48 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,310 | 11,707 | 11,512 | 11,512 | 11,509 |
| Financing Cash Flow | $10,310 | $11,707 | $11,512 | $11,512 | $11,509 |
| Beginning Cash Position | 4,565 | 2,957 | 2,957 | 2,957 | 2,957 |
| End Cash Position | 12,108 | 4,565 | 7,070 | 10,251 | 12,630 |
| Net Cash Flow | $7,543 | $1,608 | $4,113 | $7,294 | $9,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,536 | -9,764 | -7,137 | -4,095 | -1,788 |
| Capital Expenditure | -16 | -15 | -15 | -15 | N/A |
| Free Cash Flow | -2,552 | -9,779 | -7,152 | -4,110 | -1,788 |